Skip to content

Transvaginal Natural Orifice Endoscopic Surgery for Pelvic Reconstruction in the Treatment of Multi-Compartment Moderate to Severe Pelvic Organ Prolapse: A Multicenter Prospective Single-Arm Study

Transvaginal Natural Orifice Endoscopic Surgery for Pelvic Reconstruction in the Treatment of Multi-Compartment Moderate to Severe Pelvic Organ Prolapse: A Multicenter Prospective Single-Arm Study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400090616
Enrollment
Unknown
Registered
2024-10-10
Start date
2024-10-14
Completion date
Unknown
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic organ prolapse

Interventions

Experimental group:vNOTES Pelvic Reconstruction

Sponsors

Obstetrics and Gynecology Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Female patients aged 45-70; (2) According to the POP-Q score, patients with at least one compartment at stage III or higher, combined with at least one other compartment at stage II or higher; (3) Patients who refuse conservative treatment or for whom conservative treatment has failed; (4) Patients undergoing their first pelvic organ prolapse surgery who are willing to undergo surgical treatment without uterine preservation; (5) May be accompanied by stress urinary incontinence; (6) Patients who can comply with regular follow-up after surgery.

Exclusion criteria

Exclusion criteria: (1) Patients who are subjectively unwilling to accept this surgical procedure; (2) Patients with a history of pelvic organ prolapse surgery; (3) Patients with a history of hysterectomy; (4) Patients with a strong desire to preserve the uterus; (5) Patients with severe internal or external medical conditions, tumors, infections, or bleeding disorders that make surgery unsuitable; (6) Patients suspected or diagnosed with pelvic malignancies.

Design outcomes

Primary

MeasureTime frame
Surgical success rate;

Secondary

MeasureTime frame
Primary perioperative evaluation indicators;Functional outcomes;postoperative complications;

Countries

China

Contacts

Public ContactYisong Chen

Obstetrics and Gynecology Hospital of Fudan University

cys373900207@163.com+86 136 0191 3713

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026